Your Article Summary
See Latest ArticlesFluoxetine vs placebo for depressive symptoms after stroke: failed randomised controlled trial
International Journal of Geriatric Psychiatry, 08/30/07
Ruddell, M., et al. - Growth in antidepressant prescribing is a well-recognised phenomenon in developed countries. In stroke care, the evidence of effectiveness from systematic reviews is surprisingly weak. We therefore decided to undertake a randomised controlled trial comparing fluoxetine to placebo...Conclusions: In addition to the predicted practical problems of conducting an RCT in an elderly frail population, it became clear that most clinicians are not in equipoise about the value of antidepressant medication despite the lack of strong evidence for its effectiveness
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Kinematic improvement following Botulinum Toxin-A injection in upper limb spasticity due to stroke
Journal of Neurology, Neurosurgery, and Psychiatry , 12/08/09
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Journal of Psychopharmacology, 12/08/09
Today in Stroke/Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
Circuit-Based Rehabilitation Improves Gait Endurance but Not Usual Walking Activity in Chronic Stroke: A Randomized Controlled Trial
Archives of Physical Medicine and Rehabilitation, 12/08/09
What Are the Consistent Predictors of Generic and Specific Post-Stroke Health-Related Quality of Life
Cerebrovascular Diseases, 12/08/09
Cerebral Flow Velocities During Daily Activities Depend on Blood Pressure in Patients With Chronic Ischemic Infarctions
Stroke, 12/08/09